服用富马酸替诺福韦二吡呋酯的患者近端肾小管功能障碍的发生率。 - Suppr

Suppr

超能文献

Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.

作者信息

Quinn K J, Emerson C R, Dinsmore W W, Donnelly C M

出版信息

Int J STD AIDS. 2010 Feb;21(2):150-1. doi: 10.1258/ijsa.2009.009464.

DOI:10.1258/ijsa.2009.009464

PMID:20090006

Abstract

摘要

相似文献

Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.

Int J STD AIDS. 2010 Feb;21(2):150-1. doi: 10.1258/ijsa.2009.009464.

Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.

Scand J Infect Dis. 2011 Oct;43(10):821-6. doi: 10.3109/00365548.2011.577805. Epub 2011 May 12.

Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system.

AIDS Patient Care STDS. 2008 Feb;22(2):99-103. doi: 10.1089/apc.2007.0052.

Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman.

J Infect Chemother. 2012 Apr;18(2):255-7. doi: 10.1007/s10156-011-0305-3. Epub 2011 Sep 15.

Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.

J Infect. 2006 Apr;52(4):e107-8. doi: 10.1016/j.jinf.2005.07.014. Epub 2005 Aug 25.

BMJ Case Rep. 2013 Jul 9;2013:bcr2013008674. doi: 10.1136/bcr-2013-008674.

An unrecognised case of tenofovir-associated Fanconi syndrome.

Med J Aust. 2012 Feb 6;196:111-2. doi: 10.5694/mja11.11122.

Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice.

J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):301-4.

Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.

J Infect Dis. 2006 Dec 1;194(11):1471-4. doi: 10.1086/508550. Epub 2006 Oct 26.

Renal lesions in HIV-1-positive patient treated with tenofovir.

AIDS. 2003 Apr 11;17(6):935-7. doi: 10.1097/00002030-200304110-00026.

引用本文的文献

Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV.

Pharmacy (Basel). 2022 Nov 30;10(6):164. doi: 10.3390/pharmacy10060164.

The Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART Regimens.

Infect Chemother. 2015 Dec;47(4):239-46. doi: 10.3947/ic.2015.47.4.239. Epub 2015 Dec 30.

Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Eur J Clin Pharmacol. 2014 Sep;70(9):1029-40. doi: 10.1007/s00228-014-1712-z. Epub 2014 Jun 25.

Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney.

J Biomed Sci. 2013 Aug 19;20(1):61. doi: 10.1186/1423-0127-20-61.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验